Seegene Continues to Support Israel’s Effort to Manage the Omicron Variant With Timely Delivery of Five Million Tests
Seegene to export COVID-19 test that detects COVID-19 and Omicron along with its Master Assay that distinguishes between COVID-19 and other respiratory viruses SEOUL, South Korea, Jan. 17, 2022 /PRNewswire/ — Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, announced today that it has delivered over five million COVID-19 tests to Israel to help detect […]